ScholarWorks@Korea University

Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study

Full metadata record
DC Field Value Language
dc.contributor.authorKim, Sun Hwa-
dc.contributor.authorKim, Sin Gon-
dc.contributor.authorKim, Doo Man-
dc.contributor.authorWoo, Jeong-Taek-
dc.contributor.authorJang, Hak Chul-
dc.contributor.authorChung, Choon Hee-
dc.contributor.authorKo, Kyung Soo-
dc.contributor.authorPark, Jeong Hyun-
dc.contributor.authorPark, Yong Soo-
dc.contributor.authorKim, Sang Jin-
dc.contributor.authorChoi, Dong Seop-
dc.date.accessioned2021-09-04T10:17:37Z-
dc.date.available2021-09-04T10:17:37Z-
dc.date.created2021-06-18-
dc.date.issued2015-12-
dc.identifier.issn0168-8227-
dc.identifier.urihttps://scholar.korea.ac.kr/handle/2021.sw.korea/91832-
dc.description.abstractWe aimed to assess the safety and efficacy of lobeglitazone in patients with type 2 diabetes over 52 weeks through 28-week extension study. Clinical benefits in terms of glycemic and lipid control were maintained for 52 weeks. Lobeglitazone showed a favorable balance of efficacy and safety during the extension study. (C) 2015 Elsevier Ireland Ltd. All rights reserved.-
dc.languageEnglish-
dc.language.isoen-
dc.publisherELSEVIER IRELAND LTD-
dc.subjectGLYCEMIC CONTROL-
dc.subjectPARALLEL-GROUP-
dc.subjectDOUBLE-BLIND-
dc.subjectPIOGLITAZONE-
dc.subjectMETFORMIN-
dc.subjectTHIAZOLIDINEDIONES-
dc.subjectTRIAL-
dc.titleSafety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study-
dc.typeArticle-
dc.contributor.affiliatedAuthorKim, Sin Gon-
dc.contributor.affiliatedAuthorChoi, Dong Seop-
dc.identifier.doi10.1016/j.diabres.2015.09.009-
dc.identifier.scopusid2-s2.0-84955202578-
dc.identifier.wosid000366318400004-
dc.identifier.bibliographicCitationDIABETES RESEARCH AND CLINICAL PRACTICE, v.110, no.3, pp.E27 - E30-
dc.relation.isPartOfDIABETES RESEARCH AND CLINICAL PRACTICE-
dc.citation.titleDIABETES RESEARCH AND CLINICAL PRACTICE-
dc.citation.volume110-
dc.citation.number3-
dc.citation.startPageE27-
dc.citation.endPageE30-
dc.type.rimsART-
dc.type.docTypeArticle-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaEndocrinology & Metabolism-
dc.relation.journalWebOfScienceCategoryEndocrinology & Metabolism-
dc.subject.keywordPlusGLYCEMIC CONTROL-
dc.subject.keywordPlusPARALLEL-GROUP-
dc.subject.keywordPlusDOUBLE-BLIND-
dc.subject.keywordPlusPIOGLITAZONE-
dc.subject.keywordPlusMETFORMIN-
dc.subject.keywordPlusTHIAZOLIDINEDIONES-
dc.subject.keywordPlusTRIAL-
dc.subject.keywordAuthorLobeglitazone-
dc.subject.keywordAuthorThiazolidinediones-
dc.subject.keywordAuthorClinical trial-
dc.subject.keywordAuthorRandomised trial-
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles
Show simple item record

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Kim, Sin Gon photo

Kim, Sin Gon
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

STATISTICS
Total View :8,766,495
Today View :8,423

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(02841) 서울특별시 성북구 안암로 14502-3290-1114

COPYRIGHT © 2021 Korea University. All Rights Reserved.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

English